{
    "answer": "Cosentyx reported net sales of USD 1,596 million for Q4 2024, representing a +22% increase from Q4 2023 (or +24% constant currency change). For the full year 2024, the report states immunology segment sales grew US$1,620 million, leading to 152% revenue contribution to immunology accelerated to 24% year-over-year, representing a reported +72.6% compared to the full year 2023 immuno segment revenue, or a constant currency +99.5% change.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 2,
    "search count": 1,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        930,
        2797
    ]
}